Document is current
Any future updates will be listed below
-
Authors
Schiffmann, Raphael
Turnbull, James
Krupnick, Robert
Pulikottil-Jacob, Ruth https://orcid.org/0000-0003-0630-960X
Gwaltney, Chad
Hamed, Alaa
Batsu, Isabela
Heine, Walter
Mengel, Eugen
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 6 March 2025
First Online: 10 April 2025
Declarations
:
: This study was reviewed and approved by Advarra IRB (approved on 29 Nov2018) and informed consent was collected from patients and caregivers who participated in the study. The study was conducted in accordance with the protocol, applicable regulations and guidelines governing clinical study conduct, and the ethics principles given in the Declaration of Helsinki. De-identified patient data were collected in compliance with US patient confidentiality requirements, including the Health Insurance Portability and Accountability Act (HIPAA) of 1996.
: Patients and caregivers provided informed consent to publish data collected during the interviews in scientific journals.
: Raphael Schiffman has no competing interests to disclose. Alaa Hamed and Isabela Batsu are employees of Sanofi. Ruth Pulikottil-Jacob and Walter Heine were employees of Sanofi at the time of study conduct. James Turnbull and Robert Krupnick are employees of IQVIA, Inc. Chad Gwaltney is an employee of Gwaltney Consulting and was a paid consultant of Sanofi. Walter Heine was an employee of Sanofi at the time of study conduct. Eugen Mengel has received research grants, speakers’ honoraria, and consultation fees from Alexion, Amicus, Avrobio, Cyclo Therapeutics, Idorsia, Orphazyme, Sanofi, and Takeda.
